Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics Statistics

Total Valuation

YMAB has a market cap or net worth of $191.55 million. The enterprise value is $131.84 million.

Market Cap	191.55M
Enterprise Value	131.84M

Important Dates

The last earnings date was Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

YMAB has 45.28 million shares outstanding. The number of shares has increased by 2.26% in one year.

Current Share Class	45.28M
Shares Outstanding	45.28M
Shares Change (YoY)	+2.26%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	41.95%
Float	25.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.13
Forward PS	2.61
PB Ratio	2.14
P/TBV Ratio	2.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.77, with a Debt / Equity ratio of 0.01.

Current Ratio	4.77
Quick Ratio	4.12
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.93% and return on invested capital (ROIC) is -15.64%.

Return on Equity (ROE)	-29.93%
Return on Assets (ROA)	-12.62%
Return on Invested Capital (ROIC)	-15.64%
Return on Capital Employed (ROCE)	-25.43%
Revenue Per Employee	$852,481
Profits Per Employee	-$271,471
Employee Count	104
Asset Turnover	0.75
Inventory Turnover	1.96

Taxes

Income Tax	-301,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.62% in the last 52 weeks. The beta is 0.52, so YMAB's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-63.62%
50-Day Moving Average	4.47
200-Day Moving Average	9.07
Relative Strength Index (RSI)	49.97
Average Volume (20 Days)	203,870

Short Selling Information

The latest short interest is 3.09 million, so 6.82% of the outstanding shares have been sold short.

Short Interest	3.09M
Short Previous Month	3.07M
Short % of Shares Out	6.82%
Short % of Float	12.24%
Short Ratio (days to cover)	11.61

Income Statement

In the last 12 months, YMAB had revenue of $88.66 million and -$28.23 million in losses. Loss per share was -$0.63.

Revenue	88.66M
Gross Profit	72.55M
Operating Income	-23.82M
Pretax Income	-23.97M
Net Income	-28.23M
EBITDA	-23.37M
EBIT	-23.82M
Loss Per Share	-$0.63

Balance Sheet

The company has $60.31 million in cash and $603,000 in debt, giving a net cash position of $59.71 million or $1.32 per share.

Cash & Cash Equivalents	60.31M
Total Debt	603,000
Net Cash	59.71M
Net Cash Per Share	$1.32
Equity (Book Value)	89.46M
Book Value Per Share	1.98
Working Capital	71.49M

Cash Flow

In the last 12 months, operating cash flow was -$19.15 million and capital expenditures -$127,000, giving a free cash flow of -$19.28 million.

Operating Cash Flow	-19.15M
Capital Expenditures	-127,000
Free Cash Flow	-19.28M
FCF Per Share	-$0.43

Margins

Gross margin is 81.83%, with operating and profit margins of -26.87% and -31.84%.

Gross Margin	81.83%
Operating Margin	-26.87%
Pretax Margin	-32.18%
Profit Margin	-31.84%
EBITDA Margin	-26.36%
EBIT Margin	-26.87%
FCF Margin	n/a

Dividends & Yields

YMAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.26%
Shareholder Yield	-2.26%
Earnings Yield	-14.74%
FCF Yield	-10.06%

Analyst Forecast

The average price target for YMAB is $18.00, which is 326.54% higher than the current price. The consensus rating is "Buy".

Price Target	$18.00
Price Target Difference	326.54%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	9.38%
EPS Growth Forecast (5Y)	1.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

YMAB has an Altman Z-Score of 7.5 and a Piotroski F-Score of 2.

Altman Z-Score	7.5
Piotroski F-Score	2